6-aminonicotinamide has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dwarakanath, BS; Sharma, PK; Varshney, R | 1 |
1 other study(ies) available for 6-aminonicotinamide and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Radiosensitization by 2-deoxy-D-glucose and 6-aminonicotinamide involves activation of redox sensitive ASK1-JNK/p38MAPK signaling in head and neck cancer cells.
Topics: 6-Aminonicotinamide; Apoptosis; Carcinoma, Squamous Cell; Cell Proliferation; Deoxyglucose; Drug Synergism; Gamma Rays; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; MAP Kinase Kinase 4; MAP Kinase Kinase Kinase 5; Oxidation-Reduction; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Radiation Tolerance; Radiation-Sensitizing Agents; Reactive Oxygen Species; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured | 2012 |